September 18, 2025 – The members of the Center for Molecular Interactions in Cancer (CMIC, Award P20 GM152281 ), joined by the advisory committee members gathered at the Winthrop Rockefeller Institute on Petit Jean Mountain for the second Advisory Committee (AC) meeting on September 18-120, 2025. New pilot project awardees and current COBRE-funded Research Project Leaders shared the podium with CMIC Research Core Directors and staff, presenting updates on research progress and plans for the upcoming year. The AC, including our three external members Drs. Brandt Eichman, Maria Spies and Anne West along with our two UAMS members Drs. Dan Voth and Alan Tackett, provided feedback and guidance for the Center, as we enter the third year of NIH support.
The CMIC was established in 2024 upon receipt of the NIH COBRE Phase 1 award (1P20GM152281-01). The main goal of the CMIC is to advance research focused on understanding the molecular basis of cancer and cancer therapies. Advances in the instrumentation and techniques used to determine the three-dimensional properties of biomolecules have enabled researchers in a variety of disciplines to investigate complexes and interactions that were previously intractable. Structural biology and complementary biophysical approaches have the potential to advance many aspects of biomedical research. A key theme of research in the CMIC is the use of structural biology and biophysics to study the biology underlying different cancers and to promote development of new therapeutics.